Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jennifer L. Brooks is active.

Publication


Featured researches published by Jennifer L. Brooks.


Nucleosides, Nucleotides & Nucleic Acids | 2004

Synthesis of azole nucleoside 5'-monophosphate mimics (P1Ms) and their inhibitory properties of IMP dehydrogenases.

Guangyi Wang; Kandasamy Sakthivel; Vasanthakumar Rajappan; Thomas W. Bruice; Kathleen D. Tucker; Patrick Fagan; Jennifer L. Brooks; Tiffany Hurd; Janet M. Leeds; P. Dan Cook

IMPDH inhibitors have potential antimicrobial, anticancer and immunomodulatory effects. Nucleoside inhibitors of IMPDH exert their inhibitory effects via nucleoside 5′‐MPs. Conversion of nucleoside analogs to NMPs by cellular nucleoside kinases is not assured, and usually is inefficient. In order to bypass cellular phosphorylation, a series of azole nucleoside 5′‐MP mimics (P1Ms) based on ribavirin, EICAR and bredinin were synthesized and screened against human and C. albicans IMP dehydrogenises. P1Ms 8, 16, 25, 28 and 29 demonstrated substantial IMPDH inhibition with Ki values in low micromolar range. †In honor and celebration of the 70th birthday of Professor Leroy B. Townsend.


Nucleosides, Nucleotides & Nucleic Acids | 2005

2′,3′-Dideoxynucleoside 5′-β,γ-(Difluoromethylene) Triphosphates With α-P-Thio or α-P-Seleno Modifications: Synthesis and Their Inhibition of HIV-1 Reverse Transcriptase

Nicholas A. Boyle; Patrick Fagan; Jennifer L. Brooks; Marija Prhavc; John Lambert; P. Dan Cook

Nucleoside reverse transcriptase inhibitors (NRTIs) are prodrugs which require three intracellular phosphorylation steps to yield their corresponding, biologically active, nucleoside triphosphate. In order to circumvent this often inefficient phosphorylation cascade, a plausible approach is to provide the active species directly in the form of a stabilized nucleoside triphosphate mimic. We have previously shown that such a mimic, namely 5′-α-R p -borano-β,γ-(difluoromethylene) triphosphate (5′-αBCF 2 TP) is a generic triphosphate mimic that is biologically stable and can render antiviral ddNs with potent inhibitory activity against HIV-1 RT.[1] [2] Herein we report the synthesis and activity against HIV-1 RT of several ddN 5′-α-modified-β,γ-(difluoromethylene) triphosphate mimics with either a non-bridging α-P-thio (5′-αSCF 2 TP) or α-P-seleno (5′-αSeCF 2 TP) modification. One compound, namely, AZT-5′-α-P-seleno-β,γ-(difluoromethylene) triphosphate (diastereomer I), was identified as a potent inhibitor of HIV-1 RT (K i = 64 nM) and represents the first report of HIV-1 RT inhibition data for a nucleotide bearing an α-P-seleno modification. These triphosphate mimics may be useful in the investigation of enzyme mechanism and may have interesting properties with respect to drug resistance and polymerase selectivity.


Nucleosides, Nucleotides & Nucleic Acids | 2005

Synthesis of 5′-Triphosphate Mimics (P3Ms) of 3′-Azido-3′,5′-Dideoxythymidine and 3′,5′-Dideoxy-5′-Difluoromethylenethymidine as HIV-1 Reverse Transcriptase Inhibitors

Vivek K. Rajwanshi; Marija Prhavc; Patrick Fagan; Jennifer L. Brooks; Tiffany Hurd; P. Dan Cook; Guangyi Wang

3′-Azido-3′,5′-dideoxythymidine 5′-phosphonate and 3′,5′-dideoxy-5′-difluoromethylenethymidine 5′-phosphonate were prepared by multistep syntheses. The nucleoside 5′-phosphonates were converted to their triphosphates and triphosphate mimics (P3Ms) containing β,γ-difluoromethylene, β,γ-dichloromethylene, or β,γ-imodo by condensation with pyrophosphate or pyrophosphate mimics, respectively. Inhibition of HIV-1 reverse transcriptase by the nucleoside P3Ms is briefly discussed.


Journal of Medicinal Chemistry | 2004

Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase.

Anne B. Eldrup; Charles Allerson; C. Frank Bennett; Sanjib Bera; Balkrishen Bhat; Neelima Bhat; Michele Bosserman; Jennifer L. Brooks; Christine Burlein; Steven S. Carroll; P. Dan Cook; Krista Getty; Malcolm Maccoss; Daniel R. McMasters; David B. Olsen; Thazha P. Prakash; Marija Prhavc; Quanlai Song; Joanne E. Tomassini; Jie Xia


Journal of Medicinal Chemistry | 2004

Structure−Activity Relationship of Heterobase-Modified 2‘-C-Methyl Ribonucleosides as Inhibitors of Hepatitis C Virus RNA Replication

Anne B. Eldrup; Marija Prhavc; Jennifer L. Brooks; Balkrishen Bhat; Thazha P. Prakash; Quanlai Song; Sanjib Bera; Neelima Bhat; Prasad Dande; P. Dan Cook; C. Frank Bennett; Steven S. Carroll; Richard G. Ball; Michele Bosserman; Christine Burlein; Lawrence F. Colwell; John F. Fay; Osvaldo A. Flores; Krista Getty; Robert L. Lafemina; Joseph F. Leone; Malcolm Maccoss; Daniel R. McMasters; Joanne E. Tomassini; Derek Von Langen; and Bohdan Wolanski; David B. Olsen


Archive | 2003

Nucleotide mimics and their prodrugs

Phillip Dan Cook; Guangyi Wang; Thomas W. Bruice; Nicholas A. Boyle; Janet M. Leeds; Jennifer L. Brooks; Marija Prhavc; Maria Eugenia Ariza; Patrick Fagan; Yi Jin; Vivek K. Rajwanshi; Kathleen D. Tucker


Journal of Medicinal Chemistry | 2004

Synthesis of AZT 5‘-Triphosphate Mimics and Their Inhibitory Effects on HIV-1 Reverse Transcriptase

Guangyi Wang; Nicholas A. Boyle; Fu Chen; Vasanthakumar Rajappan; Patrick Fagan; Jennifer L. Brooks; Tiffany Hurd; Janet M. Leeds; Vivek K. Rajwanshi; Yi Jin; Marija Prhavc; Thomas W. Bruice; P. Dan Cook


Archive | 2003

Nucleoside 5'-monophosphate mimics and their prodrugs

Phillip Dan Cook; Guangyi Wang; Thomas W. Bruice; Vasanthankumar Rajappan; Kandasamy Sakthivel; Kathleen D. Tucker; Jennifer L. Brooks; Janet M. Leeds; Maria Eugenia Ariza; Patrick Fagan


Journal of Medicinal Chemistry | 2005

Synthesis of 2‘,3‘-Dideoxynucleoside 5‘-α-P-Borano-β,γ-(difluoromethylene)triphosphates and Their Inhibition of HIV-1 Reverse Transcriptase

Nicholas A. Boyle; Vivek K. Rajwanshi; Marija Prhavc; Guangyi Wang; Patrick Fagan; Fu Chen; Gregory Ewing; Jennifer L. Brooks; Tiffany Hurd; Janet M. Leeds; and Thomas W. Bruice; P. Dan Cook


Archive | 2003

Nukleotidmimetika und prodrugs davon

M Eugenia Ariza; Nicholas A. Boyle; Jennifer L. Brooks; Thomas W. Bruice; Phillip Dan Cook; Patrick Fagan; Yi Jin; Janet M. Leeds; Marija Prhavc; Vivek K. Rajwanshi; Kathleen D. Tucker; Guangyi Wang

Collaboration


Dive into the Jennifer L. Brooks's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nicholas A. Boyle

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge